Active	Status	Sponsor type	Region	Phase	Filter
7 Active 3 Inactive 10 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

7 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Brennan, Daniel C
NCT05917522: Assessment of Biomarker-Guided CNI Substitution In Kidney Transplantation	Recruiting	2	800	US	Abatacept, Orencia, Standard of Care at US Transplant Centers	National Institute of Allergy and Infectious Diseases (NIAID)	Kidney Transplant	07/27	07/29
NCT01309022: Immunosuppressive Medications for Participants in ITN005CT (NCT00014911)	No Longer Available	N/A		US	Sirolimus, Rapamune®, Tacrolimus, Prograf®, Mycophenolate mofetil, MMF, CellCept, Mycophenolic acid, Myfortic®	National Institute of Allergy and Infectious Diseases (NIAID), Immune Tolerance Network (ITN)	Diabetes Mellitus, Type 1
NCT04239703: Trifecta-Kidney cfDNA-MMDx Study	Recruiting	N/A	300	Europe, Canada, US, RoW	MMDx, Prospera, transplant patient blood sample, HLA antibody	University of Alberta, Natera, Inc., One Lambda	Kidney Transplant Rejection	12/25	12/26
APOLLO, NCT03615235: APOL1 Long-term Kidney Transplantation Outcomes Network	Recruiting	N/A	5000	US		Wake Forest University Health Sciences, National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	Kidney Diseases, Kidney Failure, Kidney Disease, Chronic	12/25	12/25
KOAR, NCT03326076: Evaluation of Patient Outcomes From the Kidney Allograft Outcomes AlloSure Registry	Active, not recruiting	N/A	4000	US	Donor-derived cell-free DNA (AlloSure®), Standard care, Peripheral blood gene expression profiling (AlloMap Kidney), Analytic platform (IBox)	CareDx	Kidney Transplant Rejection	06/25	12/25
Arksarapuk, Jittirat
NCT04239703: Trifecta-Kidney cfDNA-MMDx Study	Recruiting	N/A	300	Europe, Canada, US, RoW	MMDx, Prospera, transplant patient blood sample, HLA antibody	University of Alberta, Natera, Inc., One Lambda	Kidney Transplant Rejection	12/25	12/26
Carter, Katherine R
NCT04239703: Trifecta-Kidney cfDNA-MMDx Study	Recruiting	N/A	300	Europe, Canada, US, RoW	MMDx, Prospera, transplant patient blood sample, HLA antibody	University of Alberta, Natera, Inc., One Lambda	Kidney Transplant Rejection	12/25	12/26